COMMUNIQUÉS West-GlobeNewswire

EyePoint Pharmaceuticals Elects Göran Ando, M.D. as Next Chairman of Board of Directors

10/09/2018 - 13:00

WATERTOWN, Mass., Sept. 10, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]

Cyclacel Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Sapacitabine With Olaparib in BRCA Mutant Breast Cancer

10/09/2018 - 13:00

BERKELEY HEIGHTS, N.J., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on [...]

Recro Pharma to Participate in Upcoming Investor Conferences

10/09/2018 - 13:00

MALVERN, Pa., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]

Amicus Therapeutics Announces Regulatory and Clinical Updates for AT-GAA in Pompe Disease

10/09/2018 - 13:00

CRANBURY, N.J., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company focused on discovering, developing and delivering novel medicines for rare metabolic diseases, [...]

Auxly Provides Corporate Update and Highlights 2018 Milestones

10/09/2018 - 13:00

VANCOUVER, British Columbia, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX: CBWTF) (" Auxly " or the " Company ") is pleased to provide a corporate update in respect of its key [...]

Aleafia Secures First Cannabis Revenue in Sale to CannTrust

10/09/2018 - 13:00

Record Clinic Revenue in Q2 Along With Cannabis Sales to Provide Multiple Immediate Income Streams TORONTO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF) (“Aleafia“) or (the “Company [...]

A new chance for a smoke-free life - Acetium® lozenges available across Finland

10/09/2018 - 12:30

Free of nicotine and side effects, Acetium offers a totally new option for those seeking to quit smoking. Its effectiveness as a help for quitting smoking has been known for some years, and the link was confirmed in an [...]

Emblem announces proposed investment in Compass Cannabis Clinic, owner of Starbuds Canada

10/09/2018 - 12:30

TORONTO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), today announced its intention to purchase approximately $1 million of units (“ Units ”) of 10330698 Canada [...]

Digirad Corporation Announces Conversion to Holding Company Structure

10/09/2018 - 12:00

Will Acquire ATRM Holdings as an Initial “Kick-off” Transaction Immediately Hires David Noble as COO SUWANEE, Ga., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD) (“Digirad” or “DRAD”) announced [...]

Achillion Appoints Paul Firuta Chief Operating Officer

10/09/2018 - 12:00

NEW HAVEN, Conn., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) today announced the appointment of Paul Firuta to the position of Executive Vice President and Chief Operating Officer [...]

Arrayit Corporation Approved for Direct Medicare Billing by the Centers for Medicare and Medicaid Services

10/09/2018 - 11:30

Sunnyvale, Sept. 10, 2018 (GLOBE NEWSWIRE) -- September 10, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces that Arrayit’s proprietary finger stick [...]

Sorrento Therapeutics Subsidiary, Scilex, Raises $140 million in Non-Dilutive Royalty-Based Financing to Support the Commercialization of Non-Opioid ZTlido™ Pain Medication

10/09/2018 - 10:00

Scilex plans to launch ZTlido™ (lidocaine topical system) 1.8% in October 2018 SAN DIEGO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE) (“Sorrento”) announced today that its majority- [...]

Johanna Ivaska has been appointed Head & Vice President of Oncology Research in Orion Corporation

10/09/2018 - 09:01

ORION CORPORATION PRESS RELEASE 10 SEPTEMBER 2018 Johanna Ivaska has been appointed Head & Vice President of Oncology Research in Orion Corporation Johanna Ivaska (born 1972), Academy Professor of Biochemistry has [...]

Solon Eiendom ASA - Primary insider notification

10/09/2018 - 08:30

(Oslo, Norway, September 07, 2018) Solon Eiendom ASA Chairman of the Board Simen Thorsen has today through his wholly owned company Hortulan AS acquired 5,650 shares in Solon Eiendom ASA at a price of NOK 29.0211 per [...]

Xbrane Biopharma announces product portfolio update with a new full strategic focus on biosimilars

10/09/2018 - 08:01

Press release 2018-09-10 The board of directors of Xbrane Biopharma (publ.) ("Xbrane" or the Company) has decided to shift strategic focus in the Company's product pipeline to biosimilars. As Xbranes leading biosimilar [...]

A new big discovery from the Bio-on laboratories: also from the used cooking oil comes the bioplastic

10/09/2018 - 08:00

Waste oil is added to the "raw materials" already used to produce Bio-on bioplastic: beet molasses and sugar cane, fruit and potato wastes, carbohydrates in general and crude glycerol. A new discovery that transforms a [...]

Shire plc: Elections for the interim dividend in respect of the six months to June 30, 2018

10/09/2018 - 08:00

Elections for the interim dividend in respect of the six months to June 30, 2018 September 10, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announced on July 31, 2018, an interim dividend of 5.60 US cents [...]

Oxurion NV Announces New NYSE Euronext Brussels Stock Ticker "OXUR" and Launch of New Websit

10/09/2018 - 07:31

Oxurion NV trading under "OXUR" on NYSE Euronext Brussels Oxurion NV launches new global website showcasing its comprehensive drug development approach and diverse portfolio of next-generation therapies for back of the [...]

Sensorion to Partner with Vestibular Disorders Association (VeDA) in Sponsorship of Balance Awareness Week 2018 for Vestibular Disorders

10/09/2018 - 07:30

MONTPELLIER, France, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Sensorion ( FR 0012596468 – ALSEN ), a biotech company specializing in the treatment of inner ear diseases, today announces that it has joined with the Vestibular [...]